Publication of Cancellation of Entries for Kinds of Medical Devices from the Australian Register of Therapeutic Goods - Midum Health Care Pty Ltd - 208754

Overview

The Therapeutic Goods Act 1989 was enacted by the Parliament of Australia to regulate therapeutic goods, including medical devices, ensuring their safety, quality, and efficacy. The Act was introduced to address the need for a comprehensive legal framework governing the provision, advertising, and regulation of therapeutic goods within Australia. The cancellation of entries from the Australian Register of Therapeutic Goods is a mechanism provided under the Act to manage the registration of medical devices effectively, ensuring that only devices meeting the necessary safety and efficacy standards are available for use. This particular cancellation was issued by Rodolfo Ferrari, acting as a delegate of the Secretary to the Department of Health and Ageing, under section 41GP of the Act, due to an incorrect classification of the medical device in question, specifically a non-rechargeable public automated external defibrillator. The cancellation took effect on 12 September 2013, following the decision date of 9 August 2013, to uphold the policy objective of maintaining high standards in the therapeutic goods market.

Scope and Application

The Therapeutic Goods Act 1989 applies to a broad range of therapeutic goods including medicines, medical devices, blood and blood components, tissues, and vaccines within Australia. This Act regulates the manufacturing, supply, and advertising of these goods to ensure they are of acceptable quality, safety, and efficacy. It applies to individuals, entities, and businesses involved in the importation, supply, and distribution of therapeutic goods. The Act’s jurisdiction extends throughout Australia, covering both Commonwealth and state territories. There are specific exclusions within the Act, such as certain goods exempted by regulations and those governed by other legislative frameworks. The Act’s application may also be extended or restricted through subordinate instruments, such as regulations and guidelines issued by the Therapeutic Goods Administration, which provide further details on compliance and enforcement. In this particular instance, the cancellation of a medical device from the Australian Register of Therapeutic Goods highlights the Act's role in maintaining stringent standards for medical devices available in the Australian market.

Key Provisions

The Therapeutic Goods Act 1989 (the Act) provides for the regulation of therapeutic goods in Australia, including medical devices. Under section 41GP, the delegate of the Secretary to the Department of Health and Ageing has the authority to cancel an entry for a kind of medical device from the Australian Register of Therapeutic Goods (ARTG). This specific cancellation pertains to the entry with ARTG number 208754, which is for a non-rechargeable public automated external defibrillator [48047]. The cancellation was effective from 12 September 2013, following the decision made on 9 August 2013 by Rodolfo Ferrari, who was acting as the delegate for the purposes of section 41GP of the Act. The Act imposes certain obligations on the parties involved, particularly the sponsor and the manufacturer of the medical device. The sponsor, Midum Health Care Pty Ltd, and the manufacturer, Beijing M&B Electronic Instruments Co Ltd (PR China), are required to ensure that the medical device is correctly classified and that all certifications submitted are accurate. In this case, it was determined that the certification regarding the classification of the device was incorrect. This failure to comply with the classification requirements under section 41FD(c) of the Act led to the cancellation of the device's entry in the ARTG. Failure to comply with the provisions of the Therapeutic Goods Act 1989 can lead to various consequences. The Act provides for both civil and criminal penalties for breaches, depending on the nature and severity of the offence. Specifically, under section 41GP, the delegate has the authority to cancel an entry from the ARTG if certain conditions are met. While the specific maximum penalties for breaches are not detailed in this Gazette, the Act generally provides for fines and, in more severe cases, imprisonment for individuals and corporations found guilty of contravening the Act. The cancellation of the entry from the ARTG serves as a significant regulatory action to ensure the safety and efficacy of therapeutic goods in Australia.